Denosumab Zentiva 60 mg

Denosumab Zentiva 60 mg is a medicine authorised by Swissmedic under authorisation number 70492. The authorisation holder is Helvepharm AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 06 February 2026 and the authorisation is limited until 05 February 2031. ATC code M05BX04 places the medicine in the group Drugs for treatment of bone diseases.

  • Dispensing category B
  • Authorisation number 70492
  • ATC M05BX04
  • Biotechnological medicines
Authorisation data
Authorisation number70492
NameDenosumab Zentiva 60 mg
Full nameDenosumab Zentiva 60 mg, Injektionslösung (s.c.)
Authorisation holderHelvepharm AG
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeM05BX04
First authorisation06 February 2026
Authorisation validity05 February 2031
Strengths
No.NameDispensing categoryAuthorisation date
1Denosumab Zentiva 60 mg, Injektionslösung (s.c.)B06 February 2026

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Fertigspritze(n)M05BX0407.99.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Denosumab Zentiva 60 mg authorised in Switzerland?

Yes. Denosumab Zentiva 60 mg is authorised by Swissmedic under authorisation number 70492, data as of 01 September 2026. The authorisation is limited until 05 February 2031.

Which dispensing category does Denosumab Zentiva 60 mg have?

Denosumab Zentiva 60 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Denosumab Zentiva 60 mg?

The authorisation holder is Helvepharm AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com